A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies

The recruitment status of this study is unknown because the information has not been verified recently.

Verified July 2000 by National Center for Research Resources (NCRR).
Recruitment status was Active, not recruiting

Study NCT00006072 Information provided by National Center for Research Resources (NCRR)

First Received on July 25, 2000. Last Updated on June 23, 2005 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Rituxan

Additional drug interventions recognized in this trial

Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial